Reply

Paul Leong; James H. Hull; Peter G. Gibson; Thomas Halvorsen; Philip G. Bardin; on behalf of the VCD/ILO Delphi Steering Committee

doi:10.1016/j.jaci.2023.08.027

Reply

Paul Leong, James H. Hull, Peter G. Gibson, Thomas Halvorsen, Philip G. Bardin, on behalf of the VCD/ILO Delphi Steering Committee

Medicine Monash Health

Research output: Contribution to journal › Letter › Other › peer-review

Original language	English
Pages (from-to)	1688-1689
Number of pages	2
Journal	The Journal of Allergy and Clinical Immunology
Volume	152
Issue number	6
DOIs	https://doi.org/10.1016/j.jaci.2023.08.027
Publication status	Published - Dec 2023

Access to Document

10.1016/j.jaci.2023.08.027

Cite this

@article{e4e3e98efed84bad9414024d17cd70a4,

title = "Reply",

author = "Paul Leong and Hull, \{James H.\} and Gibson, \{Peter G.\} and Thomas Halvorsen and Bardin, \{Philip G.\} and \{on behalf of the VCD/ILO Delphi Steering Committee\}",

note = "Funding Information: The members of the VCD/ILO Delphi Steering Committee are as follows: Anne E. Vertigan, PhD (the John Hunter Hospital, Newcastle, Australia, and the Centre of Excellence in Treatable Traits, University of Newcastle, Newcastle, Australia); Vanessa M. McDonald, PhD (the John Hunter Hospital, Newcastle, Australia, and the Centre of Excellence in Treatable Traits, University of Newcastle, Newcastle, Australia); Mark Hew, PhD (2Monash University, Melbourne, Victoria, Australia, and the Alfred Hospital, Melbourne, Victoria, Australia), Malcolm Baxter, FRACS (Monash Health, Melbourne, Victoria, Australia, and Monash University, Melbourne, Victoria, Australia), Debra Phyland, PhD (Monash Health, Melbourne, Victoria, Australia, and Monash University, Melbourne, Victoria, Australia), Thomas L. Carroll, MD (the Department of Otolaryngology-Head and Neck Surgery, Harvard Medical School, Division of Otolaryngology-Head and Neck Surgery, Brigham and Women's Hospital, Boston, Mass), Hege Havstad Clemm, PhD (the Department of Paediatric and Adolescent Medicine, Haukeland University Hospital, Bergen, Norway, and the Faculty of Medicine, Department of Clinical Science, University of Bergen, Bergen, Norway), Maria Volls{\ae}ter, PhD (the Department of Paediatric and Adolescent Medicine, Haukeland University Hospital, Bergen, Norway, and the Faculty of Medicine, Department of Clinical Science, University of Bergen, Bergen, Norway), and Ola Drange R{\o}ksund, PhD (the Department of Paediatric and Adolescent Medicine, Haukeland University Hospital, Bergen, Norway, and the Faculty of Health and Social Sciences, Western Norway University of Applied Sciences, Bergen, Norway). All of the Steering Committee members participated in this Reply; however, journal policy limited byline authorship to 6 members.",

year = "2023",

month = dec,

doi = "10.1016/j.jaci.2023.08.027",

language = "English",

volume = "152",

pages = "1688--1689",

journal = "The Journal of Allergy and Clinical Immunology",

issn = "0091-6749",

publisher = "Elsevier",

number = "6",

}

TY - JOUR

T1 - Reply

AU - Leong, Paul

AU - Hull, James H.

AU - Gibson, Peter G.

AU - Halvorsen, Thomas

AU - Bardin, Philip G.

AU - on behalf of the VCD/ILO Delphi Steering Committee

N1 - Funding Information: The members of the VCD/ILO Delphi Steering Committee are as follows: Anne E. Vertigan, PhD (the John Hunter Hospital, Newcastle, Australia, and the Centre of Excellence in Treatable Traits, University of Newcastle, Newcastle, Australia); Vanessa M. McDonald, PhD (the John Hunter Hospital, Newcastle, Australia, and the Centre of Excellence in Treatable Traits, University of Newcastle, Newcastle, Australia); Mark Hew, PhD (2Monash University, Melbourne, Victoria, Australia, and the Alfred Hospital, Melbourne, Victoria, Australia), Malcolm Baxter, FRACS (Monash Health, Melbourne, Victoria, Australia, and Monash University, Melbourne, Victoria, Australia), Debra Phyland, PhD (Monash Health, Melbourne, Victoria, Australia, and Monash University, Melbourne, Victoria, Australia), Thomas L. Carroll, MD (the Department of Otolaryngology-Head and Neck Surgery, Harvard Medical School, Division of Otolaryngology-Head and Neck Surgery, Brigham and Women's Hospital, Boston, Mass), Hege Havstad Clemm, PhD (the Department of Paediatric and Adolescent Medicine, Haukeland University Hospital, Bergen, Norway, and the Faculty of Medicine, Department of Clinical Science, University of Bergen, Bergen, Norway), Maria Vollsæter, PhD (the Department of Paediatric and Adolescent Medicine, Haukeland University Hospital, Bergen, Norway, and the Faculty of Medicine, Department of Clinical Science, University of Bergen, Bergen, Norway), and Ola Drange Røksund, PhD (the Department of Paediatric and Adolescent Medicine, Haukeland University Hospital, Bergen, Norway, and the Faculty of Health and Social Sciences, Western Norway University of Applied Sciences, Bergen, Norway). All of the Steering Committee members participated in this Reply; however, journal policy limited byline authorship to 6 members.

PY - 2023/12

Y1 - 2023/12

UR - https://www.scopus.com/pages/publications/85173963882

U2 - 10.1016/j.jaci.2023.08.027

DO - 10.1016/j.jaci.2023.08.027

M3 - Letter

C2 - 37737751

AN - SCOPUS:85173963882

SN - 0091-6749

VL - 152

SP - 1688

EP - 1689

JO - The Journal of Allergy and Clinical Immunology

JF - The Journal of Allergy and Clinical Immunology

IS - 6

ER -

Reply

Access to Document

Other files and links

Cite this